Search

Your search keyword '"Guardigli G"' showing total 139 results

Search Constraints

Start Over You searched for: Author "Guardigli G" Remove constraint Author: "Guardigli G"
139 results on '"Guardigli G"'

Search Results

9. Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice:: GLORIA-AF Registry

10. Characterization of Italian honeys: integrating volatile and physico-chemical data.

22. Screening for atrial fibrillation in the general population: experience from a cardiovascular risk campaign in the Emilia-Romagna Region|Screening della fibrillazione atriale nella popolazione generale: esperienza della campagna educazionale sul rischio cardiovascolare della Regione Emilia-Romagna

23. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

24. Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts

26. Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry

29. Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY)

30. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

31. Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

32. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

33. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

35. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

36. Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry

44. The heart rate story

Catalog

Books, media, physical & digital resources